Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1667
Source ID: NCT03015909
Associated Drug: Somatropin
Title: Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Short Stature, Idiopathic|Infant, Small for Gestational Age|Growth Hormone Deficiency|Chronic Renal Failure|Turner Syndrome
Interventions: DRUG: Somatropin
Outcome Measures: Primary: Ease of use for EutropinPen Inj. against previous reusable device assessed by a questionnaire., Day 57|Preference for EutropinPen Inj. against previous reusable device assessed by a questionnaire., Day 57 | Secondary: Benefits of EutropinPen inj. assessed by a questionnaire, 1. Ease of use 2. Unit 3. High dose packing 4. Grip 5. Design 6. Less pain, Day 57|Fear assessed by a questionnaire, Ask of fearness how the child feels about the needle, Screening, Day 57|Ease of use for EutropinPen Inj. at each injection step assessed by a questionnaire, 1. Ask ease of use at each injection step (1\~5 pts) 2. Preparation time for injection, Screening, Day 57|Treatment compliance of EutropinPen Inj. (%), Day 57
Sponsor/Collaborators: Sponsor: LG Life Sciences
Gender: ALL
Age: CHILD
Phases: PHASE4
Enrollment: 116
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2016-08-11
Completion Date: 2017-12-21
Results First Posted:
Last Update Posted: 2019-01-03
Locations: Ajou university hospital, Suwon, Gyeong-gi, 16499, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT03015909